The report entitled The Plasma Proteins Market in Asia and Pacific 2021 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company in 17 countries, with historical data going back nine years. It analyzes the recent developments in plasma supply and fractionation, product distribution and pricing, and the introduction of new products (plasma-derived and recombinant). The major fractionators are profiled in the country where they operate, particularly in Australia, China, Japan and South Korea. This report was published in January 2023 and includes full year 2021 data and partial 2022 year events. Regional summaries are also provided to compare markets.

The report covers the following countries:

Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand and Vietnam.

The report is delivered electronically (Excel and/or pdf files). Each country chapter covers the topics listed in the table of contents of a sample country chapter below.  Individual countries are also available. This report is updated every three years. For more information or to order this report, please contact the Marketing Research Bureau at info@marketingresearchbureau.com.